Concepedia

Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study

Dominique Farge, Lucie Biard, Ben Weil, Virginie Girault, Pauline Lansiaux, I. Munia, Séverine Loisel‐Meyer, Catney Charles, J Saout, Matthieu Resche‐Rigon,

The Lancet Rheumatology · 2024 · 13 citations · 24 references

DOI

Concepts

References

24

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Katarina Le Blanc, Ida Rasmusson, Berit Sundberg et al. · The Lancet · 2004 · 2.7K citations

, , +12

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +11

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

Paul A. Blair, Lina Yassin Noreña, Fabian Flores‐Borja et al. · Immunity · 2010 · 1.5K citations · Full text

, , +16

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus

Scott A. Jenks, Kevin S. Cashman, Esther Zumaquero et al. · Immunity · 2018 · 1.1K citations · Full text

, , +17

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen et al. · Annals of the Rheumatic Diseases · 2023 · 933 citations · Full text

, , +13